Published in Int J Epidemiol on February 01, 2000
Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. World J Gastroenterol (2004) 1.15
Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an. World J Gastroenterol (2002) 1.10
Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer (2008) 1.03
TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer (2001) 0.92
Oesophageal cancer mortality in Spain: a spatial analysis. BMC Cancer (2007) 0.80
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med (1997) 4.94
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol (1997) 3.08
Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
Influence of rural environment on diagnosis, treatment, and prognosis of colorectal cancer. J Epidemiol Community Health (1992) 2.14
Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Fédération Francophone de Cancérologie Digestive. Gastroenterol Clin Biol (2008) 2.06
Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol (1995) 1.97
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg (1988) 1.87
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev (1991) 1.70
[Malignant ethmoid bone tumors in woodworkers]. J Med Lyon (1969) 1.68
Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65
Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol (2000) 1.59
How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58
Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58
Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48
Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol (1991) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur J Cancer Prev (1993) 1.44
[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40
The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg (1987) 1.40
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38
Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients. Ann Surg (1980) 1.38
[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37
[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer (1998) 1.29
Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg (2000) 1.22
Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22
Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg (2008) 1.17
Epidemiological evidence for distinguishing subsites of colorectal cancer. J Epidemiol Community Health (1989) 1.15
Influence of socioeconomic status on prognosis of colorectal cancer. A population-based study in Côte D'Or, France. Cancer (1993) 1.14
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
[Factors of early prognosis in medically treated haemorrhages of upper gastrointestinal tract in cirrhotic patients. Statistical study (author's transl)]. Pathol Biol (Paris) (1981) 1.12
Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer (2001) 1.12
Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer (1997) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg (2000) 1.11
Comparability of colorectal cancer survival data in three European population-based registries. Eur J Cancer Prev (1998) 1.11
Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol (2005) 1.11
Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev (1997) 1.10
What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol (2004) 1.10
Modelling time-dependent hazard ratios in relative survival: application to colon cancer. J Clin Epidemiol (2001) 1.08
Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev (2005) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Management and prognosis of pancreatic cancer over a 30-year period. Br J Cancer (2009) 1.07
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Haematopoietic malignancies in Côte d'Or (France): a population based study. Br J Cancer (1986) 1.03
Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol (2005) 1.03
Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut (2004) 1.02
Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut (1995) 1.01
Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis. Dig Dis Sci (1992) 1.01
[Importance of the definition of urban zones in the study of cancer risk factors]. Rev Epidemiol Sante Publique (1989) 1.00
Cerebral haemorrhage in a French prospective population study. J Neurol Neurosurg Psychiatry (1991) 1.00
Oesophageal cancer in France: potential importance of hot alcoholic drinks. Int J Cancer (1997) 1.00
Are there regional differences in the management of colon cancer in France? Eur J Cancer Prev (2005) 0.98
Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV. Phys Rev Lett (2012) 0.98
Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen (1997) 0.98
Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys (1998) 0.98
Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer (2000) 0.97
Cancer registries: their interest and practical problems. Eff Health Care (1983) 0.97
Familial relative risk of colorectal cancer: a population-based study. Eur J Cancer (2003) 0.97
Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients. Gastroenterology (1989) 0.97